Blood Oncology
Blood cancer means a huge group of incompatible malignancies. This group involves bone marrow cancers, blood cancers, and lymphatic system and lymphoid tissue cancers. Leukemia and myeloma refers to the bone marrow cancers, lymphoma refers to the lymphatic system. These are the most common types of blood cancer. Causes of these cancers are unknown. Leukemia and myeloma can interfere with the ability of bone marrow to generate blood cells, including WBC, RBC, and platelets. This can cause persistent infections and anemia. Enlargement of the lymph nodes are referred as lymphomas, can also fight against infections in the body. As well as, myelomas produce a substance which causes bones weakness, and generate abnormal proteins which can cause symptoms in other parts of the body. Treatment of blood cancers has undertaken considerable improvements. When there is no sign of cancer remission will occur. Today in the United States, Almost one million people in US are surviving with blood cancer. People with blood cancer can have complications with serious infections and bleeding. Most common cause of cancer is heavy use of Tobacco and it can cause 22% of cancer deaths. Lack of physical activity, poor diet, obesity these all are the factors of cancer.
- Carcinoma
- Sarcoma
- Mixed mesodermal tumour
Related Conference of Blood Oncology
Blood Oncology Conference Speakers
Recommended Sessions
- Blood Based Products
- Blood Disease Condition and Treatment
- Blood Oncology
- Blood Transplantation, Thrombosis and Hemostasis
- Case Reports and Epidemiology
- Diagnosis in Blood Disorder
- Hematologic Oncology
- Hematological Disorders
- Hematology and Pharma Industry
- Hematology and Stem Cell Research
- Hematology Market
- Hematology Nursing
- Immunology
- New Drug Development in Haematology
- New Drug Development in Hematology
- Pediatric Hematology
- Transfusion Medicine and Haematology Research
- Various Aspects of Hematology
Related Journals
Are you interested in
- Bleeding Disorders in Women - Blood Disorders 2024 (Ireland)
- Digital Health and Artificial Intelligence (AI) in Hematology - Blood Disorders 2024 (Ireland)
- Hematologic Gene Editing and Gene Therapies - Blood Disorders 2024 (Ireland)
- Hematology and Stem Cell Research - Blood Disorders 2024 (Ireland)
- Hematopoietic Stem Cell Transplantation - Blood Disorders 2024 (Ireland)
- Hemoglobinopathies and Sickle Cell Disease - Blood Disorders 2024 (Ireland)
- Hemophilia Management and Research - Blood Disorders 2024 (Ireland)
- Hemostasis and Thrombosis - Blood Disorders 2024 (Ireland)
- Immunotherapy and Hematology - Blood Disorders 2024 (Ireland)
- Leukemia and Lymphoma - Blood Disorders 2024 (Ireland)
- Medicine in Hematology - Blood Disorders 2024 (Ireland)
- Molecular Hematology - Blood Disorders 2024 (Ireland)
- Myelodysplastic Syndromes (MDS) and Bone Marrow Failure - Blood Disorders 2024 (Ireland)
- Next-Generation Diagnostics and Imaging - Blood Disorders 2024 (Ireland)
- Novel Therapies for Blood Cancers - Blood Disorders 2024 (Ireland)
- Pediatric Hematology - Blood Disorders 2024 (Ireland)
- Platelet Disorders - Blood Disorders 2024 (Ireland)
- Sickle Cell Disease (SCD) - Blood Disorders 2024 (Ireland)
- Thalassemia Management - Blood Disorders 2024 (Ireland)
- Transfusion Medicine and Blood Banking - Blood Disorders 2024 (Ireland)